Incorporation of EGFR mutation status into M descriptor of new TNM classification influences survival curves in non-small cell lung cancer patients Cover

.blurhash-client-img { display: none !important; }

Incorporation of EGFR mutation status into M descriptor of new TNM classification influences survival curves in non-small cell lung cancer patients

Radiology and Oncology

Volume 53 (2019): Issue 4 (December 2019)

By: Karmen Stanic, Nina Turnsek and Martina Vrankar

Open Access

|Nov 2019

Authors

Karmen Stanic

Department of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia

Nina Turnsek

Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia

Martina Vrankar

mvrankar@onko-i.si

Department of Radiotherapy, Institute of Oncology, Ljubljana, Slovenia

DOI: https://doi.org/10.2478/raon-2019-0053 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 453 - 458

Submitted on: Aug 1, 2019

|

Accepted on: Aug 30, 2019

|

Published on: Nov 20, 2019

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

EGFR mutations,

non-small cell lung cancer,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2019 Karmen Stanic, Nina Turnsek, Martina Vrankar, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 53 (2019): Issue 4 (December 2019)Next article